Buckhead Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Buckhead Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,881	Closed	-$267K	–	183
2015 Q4	$267K	Hold	3,881	–	–	0.05%	180
2015 Q3	$230K	Sell	3,881 -230	-6%	-$14.6K	0.05%	182
2015 Q2	$274K	Hold	4,111	–	–	0.05%	181
2015 Q1	$265K	Sell	4,111 -1,100	-21%	-$68.9K	0.05%	178
2014 Q4	$308K	Hold	5,211	–	–	0.05%	178
2014 Q3	$267K	Hold	5,211	–	–	0.05%	183
2014 Q2	$253K	Hold	5,211	–	–	0.04%	187
2014 Q1	$271K	Hold	5,211	–	–	0.03%	187
2013 Q4	$277K	Hold	5,211	–	–	0.04%	182
2013 Q3	$241K	Hold	5,211	–	–	0.03%	182
2013 Q2	$233K	Buy	+5,211	New	+$226K	0.03%	172

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Buckhead Capital Management's BMY Position: Q1 2016 in Review

Buckhead Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2016, closing a stake of 3,881 shares — an estimated $267K sold.

Buckhead Capital Management first reported a position in BMY in Q2 2013 and held it in 11 quarters. The position peaked at $308K in Q4 2014. 1,523 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

Buckhead Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2016 after selling out during the quarter.
Buckhead Capital Management sold 3,881 Bristol-Myers Squibb shares in Q1 2016, an estimated $267K.
Buckhead Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 11 quarters.
Buckhead Capital Management's Bristol-Myers Squibb position peaked at $308K in Q4 2014.
1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on Buckhead Capital Management's 13F filing for Q1 2016, filed 26 Apr 2016.